VolitionRx

Directions Website

VolitionRx We are dedicated to revolutionizing the diagnosis and monitoring of life-altering diseases by advancing the science of epigenetics. Early diagnosis saves lives.

Our mission is to save lives and improve outcomes for millions of people and animals worldwide. Imagine a world where diseases like cancer and sepsis can be diagnosed early and monitored easily using routine blood tests. That’s the world we’re trying to build by developing our innovative family of simple, easy to use, cost-effective Nu.Q® tests. Our patented Nucleosomics™ technology uses chromosomal structures called nucleosomes as biomarkers in cancer and other diseases. All the tests in our portfolio detect various characteristic changes in nucleosomes that occur from the earliest stages of disease, enabling early detection and potentially a better way to monitor disease progression and the patient’s response to treatment. Volition has four pillars of focus: Nu.Q®, Nu.Q® NETs, Nu.Q® Capture and Nu.Q® Vet. We are headquartered in Austin, Texas, with locations in Belgium, California, Singapore and the UK.

09/17/2026

A fantastic video featuring members of the DETECSEPs consortium

GREAT NEWS OUT TODAY: we are proud to announce our participate in DETECSEPs - France's real-wrold evaluation of Early Se...
09/17/2026

GREAT NEWS OUT TODAY: we are proud to announce our participate in DETECSEPs - France's real-wrold evaluation of Early Sepsis Detection using Volition’s Nu.Q® NETs Assay as Sole Biomarker

Read the full release

https://tinyurl.com/4rphpccf

08/26/2026

NEW VIDEO - Dr Andrew Retter discusses the Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis

Read the full press release https://tinyurl.com/3hxdr93s

GREAT NEWS OUT TODAY:Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis. Read the full release https://tinyu...
08/26/2026

GREAT NEWS OUT TODAY:

Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis.

Read the full release https://tinyurl.com/3hxdr93s

Great News Out TODAY:Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis PatientsRead more...
08/12/2026

Great News Out TODAY:
Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients

Read more https://tinyurl.com/y2feakp9

08/05/2026

Hear from Dr Ethel Rubin, Director about Voltion's Capture-Seq™ Liquid Biopsy Technology

And Read our recent press release https://tinyurl.com/2nb4ku3d

Great news out today - the publication of our first peer reviewed paper for our Capture-Seq™ Liquid Biopsy Technology.Re...
08/05/2026

Great news out today - the publication of our first peer reviewed paper for our Capture-Seq™ Liquid Biopsy Technology.

Read more about it https://tinyurl.com/2nb4ku3d

07/30/2026

A video featuring Critical Care Lead and Medical Consultant to Volition, Dr Andrew Retter highlighting the significant clinical and scientific evidence amassed for our Nu.Q® NETs product.

Read more in our Press Release https://tinyurl.com/4nnfsxdk

We were delighted to support the Golden Retriever Rescue of Southwest Florida yesterday with our Nu.Q® Vet Cancer Test
07/20/2026

We were delighted to support the Golden Retriever Rescue of Southwest Florida yesterday with our Nu.Q® Vet Cancer Test

Address

1489 West Warm Springs Road Ste 110
Henderson, NV
89014

Website

Alerts

Be the first to know and let us send you an email when VolitionRx posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category